Optimal sequential designs in phase i studies

Computational Statistics and Data Analysis

Volumn 71, Issue , 2014, Pages 288-297

  Azriel, David ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Dynamic programming; Optimal designs; Phase I studies; Sequential methods

Indexed keywords

BACKWARD INDUCTION; DYNAMIC PROGRAMMING ALGORITHM; GLOBAL OPTIMAL DESIGN; MAXIMUM TOLERATED DOSE; OPTIMAL DESIGN; OPTIMAL SEQUENTIAL; PHASE I STUDIES; SEQUENTIAL METHODS;

ALGORITHMS; DRUG DOSAGE; DYNAMIC PROGRAMMING; OPTIMAL SYSTEMS; OPTIMIZATION;

DESIGN;

EID: 84889081439     PISSN: 01679473     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.csda.2013.05.010     Document Type: Article

References (18)

1. G. Attard, A.H.M. Reid, T.A. Yap, F. Raynaud, M. Dowsett, S. Settatree, M. Barrett, C. Parker, V. Martins, E. Folkerd, J. Clark, C.S. Cooper, S.B. Kaye, D. Dearnaley, G. Lee, and J.S. de Bono Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven Journal of Clinical Oncology 26 2008 4563 4571
2. D. Azriel A note on the robustness of the continual reassessment method Statistics and Probability Letters 82 2012 902 906
3. D. Azriel, M. Mandel, and Y. Rinott The treatment versus experimentation dilemma in dose-finding studies Journal of Statistical Planning and Inference 141 2011 2759 2768
4. J. Babb, A. Rogatko, and S. Zacks Cancer phase I clinical trials: efficient dose escalation with overdose control Statistics in Medicine 17 1998 1103 1120 (Pubitemid 28221028)
5. J. Bartroff, and T.L. Lai Approximate dynamic programming and its applications to the design of phase I cancer trials Statistical Science 25 2010 245 257
6. J. Bartroff, and T.L. Lai Incorporating individual and collective ethics into phase I cancer trial designs Biometrics 67 2011 596 603
7. Y.K. Cheung, and R. Chappell A simple technique to evaluate model sensitivity in the continual reassessment method Biometrics 58 2002 671 674 (Pubitemid 35001486)
8. C.C. Drovandi, J.M. McGree, and A.N. Pettitt Sequential Monte Carlo for Bayesian sequentially designed experiments for discrete data Computational Statistics and Data Analysis 57 2013 320 335
9. L.M. Haines, I. Perevozskaya, and W.F. Rosenberger Bayesian optimal designs for Phase I clinical trials Biometrics 59 2003 591 600 (Pubitemid 37093398)
10. D. Leung, and Y. Wang An extension of the continual reassessment method using decision theory Statistics in Medicine 21 2002 51 63 (Pubitemid 34065704)
11. J. O'Quigley, and S. Chevret Methods for dose finding studies of cancer clinical trials: a review and results of a Monte Carlo study Statistics in Medicine 10 1991 1647 1664
12. J. O'Quigley, M. Pepe, and L. Fisher Continual reassessment method: a practical design for phase 1 clinical trials in cancer Biometrics 46 1990 33 48 (Pubitemid 20245604)
13. A. Oron, D. Azriel, and P. Hoff Dose-finding designs: the role of convergence properties The International Journal of Biostatistics 7 2011 Article 39
14. D.M. Potter Phase I studies of chemotherapeutic agents in cancer patients: a review of the designs Journal of Biopharmaceutical Statistics 16 2006 579 604 (Pubitemid 44844014)
15. A. Rogatko, D. Schoeneck, W. Jonas, M. Tighiouart, F.R. Khuri, and A. Porter Translation of innovative designs into phase I trials Journal of Clinical Oncology 25 2007 4982 4986 (Pubitemid 350220431)
16. W.F. Rosenberger, and L.M. Haines Competing designs for phase I clinical trials: a review Statistics in Medicine 21 2002 2757 2770
17. J. Whitehead, and H. Brunier Bayesian decision procedures for dose determining experiments Statistics in Medicine 14 1995 885 893
18. C.F.J. Wu, I. Ford, and B. Torsney The use of a canonical form in the construction of locally optimal designs for non-linear problems Journal of the Royal Statistical Society. Series B (Methodological) 54 1992 569 583